Mirum Pharmaceuticals, Inc. MIRM Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
- Mirum Pharmaceuticals, Inc. (MIRM) reported increase (decrease) in prepaid expense and other assets of $6.63M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets increased by 118.9% year-over-year, from $3.03M to $6.63M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2021 to 2023), Mirum Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -5.2% compound annual growth rate (CAGR), from $4.01M to $3.6M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.